Cargando…

Safety assessment of microsilver-loaded poly(methyl methacrylate) (PMMA) cement spacers in patients with prosthetic hip infections: Results of a prospective cohort study

OBJECTIVES: Preclinical data showed poly(methyl methacrylate) (PMMA) loaded with microsilver to be effective against a variety of bacteria. The purpose of this study was to assess patient safety of PMMA spacers with microsilver in prosthetic hip infections in a prospective cohort study. METHODS: A t...

Descripción completa

Detalles Bibliográficos
Autores principales: Alt, Volker, Rupp, Markus, Lemberger, Karsten, Bechert, Thorsten, Konradt, Thomas, Steinrücke, Peter, Schnettler, Reinhard, Söder, Stephan, Ascherl, Rudolf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6719530/
https://www.ncbi.nlm.nih.gov/pubmed/31537996
http://dx.doi.org/10.1302/2046-3758.88.BJR-2018-0270.R1
_version_ 1783447955704905728
author Alt, Volker
Rupp, Markus
Lemberger, Karsten
Bechert, Thorsten
Konradt, Thomas
Steinrücke, Peter
Schnettler, Reinhard
Söder, Stephan
Ascherl, Rudolf
author_facet Alt, Volker
Rupp, Markus
Lemberger, Karsten
Bechert, Thorsten
Konradt, Thomas
Steinrücke, Peter
Schnettler, Reinhard
Söder, Stephan
Ascherl, Rudolf
author_sort Alt, Volker
collection PubMed
description OBJECTIVES: Preclinical data showed poly(methyl methacrylate) (PMMA) loaded with microsilver to be effective against a variety of bacteria. The purpose of this study was to assess patient safety of PMMA spacers with microsilver in prosthetic hip infections in a prospective cohort study. METHODS: A total of 12 patients with prosthetic hip infections were included for a three-stage revision procedure. All patients received either a gentamicin-PMMA spacer (80 g to 160 g PMMA depending on hip joint dimension) with additional loading of 1% (w/w) of microsilver (0.8 g to 1.6 g per spacer) at surgery 1 followed by a gentamicin-PMMA spacer without microsilver at surgery 2 or vice versa. Implantation of the revision prosthesis was carried out at surgery 3. RESULTS: In total, 11 of the 12 patients completed the study. No argyria or considerable differences in laboratory parameters were detected. Silver blood concentrations were below or around the detection limit of 1 ppb in ten of the 11 patients. A maximum of 5.6 ppb at 48 hours after implantation of the silver spacer, which is below the recommended maximum level of 10 ppb, was found in one patient. No silver was detected in the urine. Drainage fluids showed concentrations between 16.1 ppb and 23.3 ppb at 12 hours after implantation of the silver spacers, and between 16.8 ppb to 25.1 ppb at 48 hours after implantation. Pathohistological assessment of the periprosthetic membrane did not reveal any differences between the two groups. CONCLUSION: Microsilver-loaded gentamicin-PMMA spacers showed good biocompatibility and the broad antimicrobial activity warrants further clinical research to assess its effectivity in reducing infection rates in prosthetic joint infection. Cite this article: V. Alt, M. Rupp, K. Lemberger, T. Bechert, T. Konradt, P. Steinrücke, R. Schnettler, S. Söder, R. Ascherl. Safety assessment of microsilver-loaded poly(methyl methacrylate) (PMMA) cement spacers in patients with prosthetic hip infections: Results of a prospective cohort study. Bone Joint Res 2019;8:387–396. DOI: 10.1302/2046-3758.88.BJR-2018-0270.R1.
format Online
Article
Text
id pubmed-6719530
institution National Center for Biotechnology Information
language English
publishDate 2019
record_format MEDLINE/PubMed
spelling pubmed-67195302019-09-19 Safety assessment of microsilver-loaded poly(methyl methacrylate) (PMMA) cement spacers in patients with prosthetic hip infections: Results of a prospective cohort study Alt, Volker Rupp, Markus Lemberger, Karsten Bechert, Thorsten Konradt, Thomas Steinrücke, Peter Schnettler, Reinhard Söder, Stephan Ascherl, Rudolf Bone Joint Res Infection OBJECTIVES: Preclinical data showed poly(methyl methacrylate) (PMMA) loaded with microsilver to be effective against a variety of bacteria. The purpose of this study was to assess patient safety of PMMA spacers with microsilver in prosthetic hip infections in a prospective cohort study. METHODS: A total of 12 patients with prosthetic hip infections were included for a three-stage revision procedure. All patients received either a gentamicin-PMMA spacer (80 g to 160 g PMMA depending on hip joint dimension) with additional loading of 1% (w/w) of microsilver (0.8 g to 1.6 g per spacer) at surgery 1 followed by a gentamicin-PMMA spacer without microsilver at surgery 2 or vice versa. Implantation of the revision prosthesis was carried out at surgery 3. RESULTS: In total, 11 of the 12 patients completed the study. No argyria or considerable differences in laboratory parameters were detected. Silver blood concentrations were below or around the detection limit of 1 ppb in ten of the 11 patients. A maximum of 5.6 ppb at 48 hours after implantation of the silver spacer, which is below the recommended maximum level of 10 ppb, was found in one patient. No silver was detected in the urine. Drainage fluids showed concentrations between 16.1 ppb and 23.3 ppb at 12 hours after implantation of the silver spacers, and between 16.8 ppb to 25.1 ppb at 48 hours after implantation. Pathohistological assessment of the periprosthetic membrane did not reveal any differences between the two groups. CONCLUSION: Microsilver-loaded gentamicin-PMMA spacers showed good biocompatibility and the broad antimicrobial activity warrants further clinical research to assess its effectivity in reducing infection rates in prosthetic joint infection. Cite this article: V. Alt, M. Rupp, K. Lemberger, T. Bechert, T. Konradt, P. Steinrücke, R. Schnettler, S. Söder, R. Ascherl. Safety assessment of microsilver-loaded poly(methyl methacrylate) (PMMA) cement spacers in patients with prosthetic hip infections: Results of a prospective cohort study. Bone Joint Res 2019;8:387–396. DOI: 10.1302/2046-3758.88.BJR-2018-0270.R1. 2019-09-03 /pmc/articles/PMC6719530/ /pubmed/31537996 http://dx.doi.org/10.1302/2046-3758.88.BJR-2018-0270.R1 Text en © 2019 Author(s) et al. https://creativecommons.org/licenses/by-nc/4.0/ Open Access This article is distributed under the terms of the Creative Commons Attribution-Non Commercial 4.0 International (CC BY-NC 4.0) licence (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed.
spellingShingle Infection
Alt, Volker
Rupp, Markus
Lemberger, Karsten
Bechert, Thorsten
Konradt, Thomas
Steinrücke, Peter
Schnettler, Reinhard
Söder, Stephan
Ascherl, Rudolf
Safety assessment of microsilver-loaded poly(methyl methacrylate) (PMMA) cement spacers in patients with prosthetic hip infections: Results of a prospective cohort study
title Safety assessment of microsilver-loaded poly(methyl methacrylate) (PMMA) cement spacers in patients with prosthetic hip infections: Results of a prospective cohort study
title_full Safety assessment of microsilver-loaded poly(methyl methacrylate) (PMMA) cement spacers in patients with prosthetic hip infections: Results of a prospective cohort study
title_fullStr Safety assessment of microsilver-loaded poly(methyl methacrylate) (PMMA) cement spacers in patients with prosthetic hip infections: Results of a prospective cohort study
title_full_unstemmed Safety assessment of microsilver-loaded poly(methyl methacrylate) (PMMA) cement spacers in patients with prosthetic hip infections: Results of a prospective cohort study
title_short Safety assessment of microsilver-loaded poly(methyl methacrylate) (PMMA) cement spacers in patients with prosthetic hip infections: Results of a prospective cohort study
title_sort safety assessment of microsilver-loaded poly(methyl methacrylate) (pmma) cement spacers in patients with prosthetic hip infections: results of a prospective cohort study
topic Infection
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6719530/
https://www.ncbi.nlm.nih.gov/pubmed/31537996
http://dx.doi.org/10.1302/2046-3758.88.BJR-2018-0270.R1
work_keys_str_mv AT altvolker safetyassessmentofmicrosilverloadedpolymethylmethacrylatepmmacementspacersinpatientswithprosthetichipinfectionsresultsofaprospectivecohortstudy
AT ruppmarkus safetyassessmentofmicrosilverloadedpolymethylmethacrylatepmmacementspacersinpatientswithprosthetichipinfectionsresultsofaprospectivecohortstudy
AT lembergerkarsten safetyassessmentofmicrosilverloadedpolymethylmethacrylatepmmacementspacersinpatientswithprosthetichipinfectionsresultsofaprospectivecohortstudy
AT bechertthorsten safetyassessmentofmicrosilverloadedpolymethylmethacrylatepmmacementspacersinpatientswithprosthetichipinfectionsresultsofaprospectivecohortstudy
AT konradtthomas safetyassessmentofmicrosilverloadedpolymethylmethacrylatepmmacementspacersinpatientswithprosthetichipinfectionsresultsofaprospectivecohortstudy
AT steinruckepeter safetyassessmentofmicrosilverloadedpolymethylmethacrylatepmmacementspacersinpatientswithprosthetichipinfectionsresultsofaprospectivecohortstudy
AT schnettlerreinhard safetyassessmentofmicrosilverloadedpolymethylmethacrylatepmmacementspacersinpatientswithprosthetichipinfectionsresultsofaprospectivecohortstudy
AT soderstephan safetyassessmentofmicrosilverloadedpolymethylmethacrylatepmmacementspacersinpatientswithprosthetichipinfectionsresultsofaprospectivecohortstudy
AT ascherlrudolf safetyassessmentofmicrosilverloadedpolymethylmethacrylatepmmacementspacersinpatientswithprosthetichipinfectionsresultsofaprospectivecohortstudy